TNFRSF1A and Miyoshi myopathy: Furthermore, in immunocompetent mice, TNFRSF1A silencing suppressed the tumorigenesis of MM cells, indicating that TNFRSF1A leads to carfilzomib resistance by diminishing antitumor immunity.